Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 3617-3620, July 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, P. A.
Right arrow Articles by Pike, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, P. A.
Right arrow Articles by Pike, M. C.

From Gene to Carcinogen: A Rapidly Evolving Field in Molecular Epidemiology

Peter A. Jones1, Jonathan D. Buckley, Brian E. Henderson, Ronald K. Ross and Malcolm C. Pike

Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90033

Chemical and physical carcinogens leave footprints of their activities on DNA because of the patterns of base changes they induce. Additionally, the conversion of 5-methylcytosine to thymine in CpG sequences leads to a characteristic mutation which can be used to estimate the contribution of endogenous processes to human mutations. Knowledge of the pattern mutations found in genes commonly mutated in human cancer, such as the p53 tumor suppressor gene, allows for predictions to be made on the likelihood of an exogenous DNA-damaging agent being involved. Working from gene to carcinogen is likely to have a profound impact on our understanding of the origins of human cancer.

1 To whom requests for reprints should be addressed, at Institute of Animal Physiology and Genetics Research, Babraham, Cambridge CB2 4AT, United Kingdom.

Received 5/ 2/91. Accepted 5/16/91.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
I.A. Lea, M.A. Jackson, X. Li, S. Bailey, S.D. Peddada, and J.K. Dunnick
Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns
Carcinogenesis, September 1, 2007; 28(9): 1851 - 1858.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
C. Diaz-Castillo and K. G. Golic
Evolution of Gene Sequence in Response to Chromosomal Location
Genetics, September 1, 2007; 177(1): 359 - 374.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Liu, M. Hergenhahn, H. H. Schmeiser, G. N. Wogan, A. Hong, and M. Hollstein
Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene
PNAS, March 2, 2004; 101(9): 2963 - 2968.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Ueki, A. W. Hsing, Y.-T. Gao, B.-S. Wang, M.-C. Shen, J. Cheng, J. Deng, J. F. Fraumeni Jr., and A. Rashid
Alterations of p16 and Prognosis in Biliary Tract Cancers from a Population-Based Study in China
Clin. Cancer Res., March 1, 2004; 10(5): 1717 - 1725.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. C. Schroeder, K. Conway, Y. Li, K. Mistry, D. A. Bell, and J. A. Taylor
p53 Mutations in Bladder Cancer: Evidence for Exogenous versus Endogenous Risk Factors
Cancer Res., November 1, 2003; 63(21): 7530 - 7538.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Shibata, J. Parsonnet, T. A. Longacre, M. I. Garcia, B. Puligandla, R.E. Davis, J. H. Vogelman, N. Orentreich, and L. A. Habel
CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma
Carcinogenesis, March 1, 2002; 23(3): 419 - 424.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
E. C. Lazcano-Ponce, J. F. Miquel, N. Munoz, R. Herrero, C. Ferrecio, I. I. Wistuba, P. Alonso de Ruiz, G. Aristi Urista, and F. Nervi
Epidemiology and Molecular Pathology of Gallbladder Cancer
CA Cancer J Clin, November 1, 2001; 51(6): 349 - 364.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. B. Ness and C. Cottreau
Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer
J Natl Cancer Inst, September 1, 1999; 91(17): 1459 - 1467.
[Abstract] [Full Text] [PDF]


Home page
J Oncol Pharm PractHome page
E. Perz and J. G. Kuhn
Review : p53 in the pathogenesis, diagnosis, and treatment of cancer
Journal of Oncology Pharmacy Practice, June 1, 1998; 4(2): 75 - 102.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
Y. Sun, G. Hegamyer, H. Kim, K. Sithanandam, H. Li, R. Watts, and N. H. Colburn
Molecular Cloning of Mouse Tissue Inhibitor of Metalloproteinases-3 and Its Promoter
J. Biol. Chem., August 18, 1995; 270(33): 19312 - 19319.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. C. Harris and M. Hollstein
Clinical Implications of the p53 Tumor-Suppressor Gene
N. Engl. J. Med., October 28, 1993; 329(18): 1318 - 1327.
[Full Text]


Home page
ScienceHome page
B. Henderson, R. Ross, and M. Pike
Toward the primary prevention of cancer
Science, November 22, 1991; 254(5035): 1131 - 1138.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.